Zhang, Y., et al.. High-dimensional Immune Profiling of Dimethyl Fumarate and Ocrelizumab in Multiple Sclerosis. Cold Spring Harbor Laboratory, 10 Nov. 2022, doi:10.1101/2022.11.05.22281806.